Real-World Use of Iptacopan in IgAN: A Retrospective Longitudinal Study in a Single Center (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #TH-PO0467; Pres time: Oct 22, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Conclusion In this study, Iptacopan use in IgAN was associated with substantial proteinuria reduction, improvement in hematuria, and stable kidney function over short-term follow-up though long term is needed to assess durability of response. Treatment response to Iptacopan"
Longitudinal study • Observational data • Real-world • Real-world evidence • Retrospective data • Glomerulonephritis • IgA Nephropathy • Renal Disease
|
|
Prabesh Aryal; Tripti Singh
|